Top 50 Ai Diagnostics in Asia

IBEX develops AI-powered diagnostic solutions that enhance the accuracy and efficiency of cancer detection by analyzing tissue samples with deep learning algorithms trained on over 10 million pathology slides. This technology provides pathologists with reliable insights, improving diagnostic confidence and patient outcomes in cancer care.

The startup operates an AI-based diagnostic platform that enables rapid blood analysis directly at peripheral clinics, eliminating the need for extensive maintenance and operational costs. This technology enhances diagnostic accuracy and significantly reduces the time required for obtaining test results, improving patient care in underserved areas.

VinBrain provides artificial intelligence solutions for medical image diagnostics, utilizing deep learning algorithms to enhance the accuracy of radiological assessments. By automating image analysis, VinBrain reduces the time required for diagnosis and improves clinical decision-making in healthcare settings.

Aillis is developing an AI-powered medical device that enables early and accurate detection of influenza through advanced diagnostic algorithms. This technology addresses the challenge of timely identification of influenza infections, facilitating prompt treatment and reducing the spread of the virus.

Viseur AI provides AI-powered radiology and digital pathology solutions that enhance the accuracy and speed of medical image interpretation, enabling healthcare professionals to make precise diagnoses. The platform integrates seamlessly with existing healthcare IT systems, improving diagnostic confidence and workflow efficiency while ensuring secure data handling.

AI Medical Service develops AI-powered diagnostic software for endoscopic imaging to enhance the detection of gastric and colorectal cancers. Their technology addresses the issue of missed early-stage cancers during endoscopic examinations, which can lead to higher mortality rates.

Endimension develops AI-driven tools for medical image analysis that enhance diagnostic accuracy and streamline radiology reporting workflows. By automating the identification and quantification of abnormalities, their solutions improve efficiency and reduce the risk of diagnostic errors in imaging centers.

Develops an AI-powered digital pathology platform that integrates with major laboratory information systems (LIS) and electronic medical records (EMR) to automate and standardize cancer diagnosis. By analyzing whole-slide images in seconds and providing a vendor-agnostic workflow, it improves diagnostic accuracy, reduces costs, and enables remote pathology, allowing pathologists to focus on complex cases.

MEDHINI is a generative AI-powered software platform that provides genomics-based multimodal solutions for healthcare diagnostics, focusing on areas such as antimicrobial resistance and virtual clinical trials. The platform enhances diagnostic accuracy and accessibility in pulmonology, neurology, nephrology, cardiology, and oncology, addressing the need for affordable healthcare solutions with measurable social impact.

5C Network provides teleradiology services utilizing AI-driven analysis for MRI, CT, PETCT, and X-ray scans, enabling autonomous detection of pathologies and generating preliminary reports for urgent cases. This technology enhances diagnostic accuracy and reduces turnaround times, improving workflow efficiency for radiologists and healthcare providers.

Diagnostic Robotics develops a signal-agnostic artificial intelligence system that utilizes predictive analytics to enhance patient triage and monitoring for healthcare insurers, providers, and patients. The platform aims to reduce care costs and improve health outcomes by optimizing patient management and engagement in value-based care settings.

See-Mode utilizes AI algorithms to automatically analyze thyroid and breast ultrasound images, generating precise TI-RADS and BI-RADS reports that enhance diagnostic accuracy. This technology addresses the issues of prolonged reporting times and variability in operator assessments, ensuring consistent and reliable results for radiologists.

FathomX develops FxMammo, an AI Assistant that utilizes machine learning algorithms to analyze mammograms, significantly reducing false positive and negative rates while streamlining the clinical workflow. The technology enhances early breast cancer detection by providing radiologists with precise, data-driven insights, thereby improving diagnostic accuracy and efficiency.

EyeCheckup utilizes artificial intelligence to analyze fundus images and detect over 20 retinal diseases, including diabetic retinopathy and glaucoma, with a diagnostic accuracy of 96%. This system enables early identification of eye, heart, and kidney diseases, facilitating timely referrals to specialists and reducing the risk of blindness and vision loss.

The startup develops a health monitoring device that utilizes artificial intelligence to create biomedical solutions for early disease prevention and diagnosis. This technology enhances accessibility and affordability in cardiac health diagnostics, enabling healthcare providers to identify risk factors and diseases at an earlier stage.

CranioCatch utilizes artificial intelligence algorithms to analyze 2D and 3D radiological images, providing rapid and accurate diagnoses for dental professionals. This technology enhances patient follow-up and treatment planning by delivering results within seconds, significantly improving the efficiency of clinical workflows.

The startup develops an AI-based decision support system specifically for the radiology industry, offering teleradiology services and radiology optimization platforms. This technology enables radiologists to manage their workload more efficiently and accelerate the diagnostic process.

Ai Health Highway develops AiSteth, a smart stethoscope that utilizes AI and machine learning to visualize and analyze heart and lung sounds, enabling accurate detection of anomalies. The technology aims to enhance chronic disease screening in primary care clinics, addressing the high mortality rates associated with noncommunicable diseases through early detection and intervention.

Mito Health utilizes AI-driven analysis of over 100 biomarkers from blood tests to provide personalized health insights and risk assessments for chronic diseases. This approach enables users to monitor their health, optimize performance, and implement actionable strategies for disease prevention and overall well-being.

The startup offers an AI-powered platform that diagnoses performance inconsistencies in process manufacturing and provides real-time insights and predictive diagnostics. This technology enables operators to enhance throughput, minimize energy consumption, and improve product quality while reducing operational costs.

AmplifAI Health utilizes portable thermal cameras and computer vision technology to enhance diagnostic accuracy in healthcare, specifically targeting diabetic foot ulcers. The platform enables real-time anomaly detection, improving patient outcomes and reducing the costs associated with traditional diagnostic methods.

Sanolla offers an AI-powered diagnostic platform that utilizes infrasound analysis to monitor and detect early exacerbations in patients with Congestive Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD) from home. This technology enables real-time self-assessment, providing critical clinical data that enhances patient care while reducing healthcare costs.

MetaDx develops an AI-based veterinary diagnostic platform that includes VitalVET for real-time anesthesia monitoring and CancerVET for early tumor detection through biomarker analysis. This technology addresses the shortage of specialized anesthesiologists and enhances the accuracy of cancer screenings, improving treatment outcomes for pets.

MICA develops an AI decision support system that enhances mammography analysis by accurately diagnosing suspicious findings in breast tissue, particularly in dense breasts. This technology addresses the issue of outdated detection methods that lead to errors, enabling earlier and more effective treatment for breast cancer.

a2z Radiology AI develops the a2z-1, a multi-disease AI model that analyzes abdomen-pelvis CT scans to detect 21 actionable conditions, including appendicitis and aortic aneurysms. This technology provides a second look at radiologist reports, identifying discrepancies and enhancing diagnostic accuracy to improve patient outcomes.

Hevi AI develops deep learning software that enhances the accuracy and speed of radiological interpretations, specifically for stroke diagnosis. By analyzing over one million exams, their technology significantly reduces diagnostic time and improves patient outcomes in emergency care settings.

Dentifrice offers a diagnostic imaging analysis platform that utilizes AI to provide instant evaluations of uploaded dental images. This technology enables users to identify oral health issues quickly, ensuring timely intervention and improved dental care.

The startup has developed an artificial intelligence-based diagnostic support system that utilizes electrocardiogram data to detect atrial fibrillation at an early stage. This automated analysis provides accuracy comparable to that of a specialist, enabling healthcare professionals to improve diagnosis and treatment for heart disease patients globally.

UltraSight develops AI-driven software that provides real-time guidance and quality assessment for cardiac ultrasound imaging, enabling healthcare professionals to capture diagnostic-quality images regardless of their sonography experience. This technology enhances the accessibility and accuracy of cardiac diagnostics in various settings, including clinics and remote areas, facilitating timely clinical decisions for patients.

CYBO develops an AI-driven platform for cell analysis that utilizes high-speed imaging and deep learning to classify and sort cells efficiently. This technology enhances applications in medical diagnostics and pharmaceutical production by providing rapid and accurate cell characterization, addressing the challenges of traditional cell analysis methods.

The startup develops an AI-based image analysis software for magnetic resonance imaging (MRI) that incorporates clinical diagnostic logic to enhance the accuracy of neurological disease diagnosis. This technology enables medical professionals to achieve early detection and staging of Alzheimer's and Parkinson's diseases, improving patient outcomes through precise identification of brain damage levels.

Medantrik manufactures AI-powered diagnostic devices and a mobile application that provide personalized monitoring and management of asthma and lung conditions. The technology enhances diagnostic accuracy and enables users to manage their lung health remotely, reducing the need for frequent clinic visits.

Manentia AI develops an integrated artificial intelligence system for medical imaging that utilizes deep learning algorithms to accurately detect and localize anomalies in chest X-rays and CT scans. This technology enhances diagnostic precision and reduces turnaround time, enabling radiologists to improve cancer detection and treatment planning.

ZebraEye utilizes artificial intelligence to analyze ophthalmic images for the rapid detection of rare eye diseases, achieving results in under one minute. This technology addresses the high misdiagnosis rate of over 40% in rare eye conditions, significantly reducing the risk of improper treatment and potential vision loss.

RareSum is an AI-powered reference tool designed for rare disease diagnostics, enabling healthcare professionals to create detailed patient profiles and conduct deep searches for relevant testing options. This platform reduces research time and enhances diagnostic accuracy by providing tailored information for individual patients, regardless of geographic location.

AISAP LTD offers a point-of-care ultrasound platform that utilizes AI algorithms for real-time diagnosis and interpretation of ultrasound studies, enabling immediate clinical decision-making. This technology addresses delays in diagnosis and enhances patient outcomes by providing accurate assessments quickly, integrating seamlessly into existing healthcare workflows.

The startup offers an AI-driven diagnostics platform that utilizes machine learning algorithms to analyze skin images and identify various skin disorders. This technology provides dermatologists with accurate, rapid assessments, reducing the time needed for diagnosis and improving patient outcomes.

ThetaLabs AI offers a portable kiosk-based primary care clinic that integrates micro diagnostics, teleconsulting, and telemedicine, enabling rapid health assessments with over 20 tests in just 10 minutes. This solution addresses the need for accessible and affordable healthcare by providing high-accuracy diagnostics and instant doctor consultations at a fraction of traditional costs.

Aivisiontech utilizes artificial intelligence to analyze data from various imaging modalities, enhancing diagnostic accuracy in medical imaging. The company addresses the challenge of inefficient data interpretation, enabling healthcare professionals to make faster and more informed decisions.

PhenoTA utilizes advanced AI algorithms to analyze blood cell data from routine blood tests, providing detailed insights into individual health conditions. This technology enhances medical decision-making by delivering precise, actionable information that can lead to earlier diagnosis and improved patient outcomes.

Adiuvo Diagnostics develops a multispectral autofluorescence imaging device that utilizes machine learning algorithms for rapid, label-free disease detection, tailored for low-resource environments. This technology addresses the need for efficient early diagnosis of pathogens, skin conditions, and cancer, improving healthcare outcomes in underserved areas.

BioScan AI utilizes artificial intelligence to analyze retinal images for the early detection of systemic diseases such as Chronic Kidney Disease, Diabetic Retinopathy, and Breast Cancer, providing results in under 60 seconds. The platform offers a non-invasive screening solution that enhances accessibility and reduces the need for on-site eye care specialists, making timely health assessments more efficient and affordable.

OutSense Diagnostics has developed an IoT device that attaches to a toilet bowl to autonomously analyze human waste, providing real-time health diagnostics through advanced imaging algorithms and AI. This technology enables early detection of medical conditions such as colorectal cancer and urinary tract infections, facilitating timely intervention and personalized healthcare.

InMed Prognostics provides an AI and machine learning-based MRI tool designed for neuro radiologists, neuro physicians, and psychiatrists. This technology enhances diagnostic accuracy by analyzing brain imaging data to identify neurological conditions more effectively.

Pearl is a real-time dental AI platform that utilizes advanced image analysis to automatically detect various conditions in dental x-rays, enhancing diagnostic accuracy by up to 37%. This technology provides dentists with a reliable second opinion, reducing the risk of missed pathologies and improving patient care.

The startup operates a customized medical AI platform that provides cloud-based AI medical diagnosis assistance and PACS services, enabling healthcare professionals to access diagnostic support without altering their existing workflows. This platform addresses the need for accessible and efficient medical diagnosis tools, allowing for timely decision-making in various clinical environments.

InnovXcare develops AI-driven tools for Radiology, Pathology, and Oncology to enhance diagnostic accuracy and streamline clinical workflows. The company focuses on improving access to high-quality healthcare, aiming to deliver timely and equitable patient care in India and globally.

The startup has developed an AI-assisted platform for identifying bacteria using gram stain images, specimens, and symptoms captured with optical microscopes. This technology enables clinicians to accurately determine the causative bacteria in infectious diseases, facilitating the selection of appropriate antibiotics to combat life-threatening infections.

Qure.ai utilizes deep learning and artificial intelligence to enhance the detection and management of tuberculosis, lung cancer, and stroke through advanced medical imaging analysis. By providing rapid and accurate diagnostic support, Qure.ai improves treatment planning and patient outcomes across over 90 countries, impacting more than 25 million lives.

IMedis utilizes artificial intelligence algorithms to analyze medical imaging data for the early detection of cancerous lesions. The company addresses the challenge of late-stage cancer diagnosis by providing healthcare professionals with timely and accurate insights, improving patient outcomes.